Make Europe Healthy Again: US Health Movement Expands to Brussels

LONDON — A movement born in the United States is gaining traction across Europe, fueled by concerns over chronic disease, environmental health, and scientific transparency. What began as “Make America Healthy Again” (MAHA) has spawned “Make Europe Healthy Again” (MEHA), a new organization actively lobbying for changes in public health policy across the continent. The transatlantic echo reflects a growing, if still fringe, sentiment questioning established approaches to health and wellness.

The formal launch of MEHA took place last autumn at the European Parliament in Brussels, featuring a presentation by Robert W. Malone, a physician and prominent advisor to U.S. Health Secretary Robert F. Kennedy Jr. Malone, recently selected as an advisor to the U.S. Centers for Disease Control and Prevention by Kennedy Jr., highlighted what he perceives as Europe’s superior capacity for gathering and analyzing health data, particularly regarding Covid-19 vaccine impacts. He specifically praised the data collection systems in Nordic countries and the United Kingdom, suggesting the U.S. Faces barriers to robust epidemiological analysis due to its healthcare system and patient confidentiality regulations. As reported by Politico, Malone argued that better data from Europe may explain why some European nations are reporting different outcomes related to Covid-19 vaccine harms.

A Shared Platform of Concerns

MEHA, founded by Maria Hubmer-Mogg, shares core tenets with its American counterpart. The organization’s stated aims include preventing chronic diseases, protecting the environment, promoting scientific transparency, and empowering Europeans to “reclaim [their] health and sovereignty.” According to MEHA’s website, the group intends to lobby European governments on a range of issues, including regenerative farming practices, healthier school meals, and limiting children’s screen time. Hubmer-Mogg explained at the Brussels launch event that MEHA will serve as a platform for advocating these health priorities.

The focus on regenerative agriculture is particularly noteworthy. Regenerative farming, a conservation and rehabilitation approach to food and farming systems, aims to improve soil health, biodiversity, and water cycles. STAT News reported on the MAHA movement’s embrace of regenerative agriculture, highlighting the involvement of chef-turned-farmer Ryland Engelhart. This emphasis reflects a broader trend of linking dietary health to environmental sustainability.

Echoes of the MAHA Campaign

The emergence of MEHA is directly linked to the MAHA movement spearheaded by Robert F. Kennedy Jr. Kennedy Jr.’s campaign, known as “Make America Healthy Again,” has gained prominence through its criticism of conventional medicine, particularly regarding vaccines and pharmaceutical interventions. He has also advocated for restricting access to Covid-19 vaccines in the U.S., citing concerns about potential side effects, and has questioned the safety of common ingredients like paracetamol (Tylenol), linking its use to autism rates. These positions, whereas controversial, have resonated with a segment of the population skeptical of established health authorities.

Europe’s approach to Covid-19 vaccination during the pandemic differed from that of the U.S., with many European countries restricting vaccine eligibility to those at highest risk and carefully weighing potential side effects. This approach, particularly the recognition of a rare heart condition risk among younger men and teenagers, has been cited by Kennedy Jr. As evidence of a more cautious and scientifically sound approach to public health. The Politico report notes that under Kennedy Jr., the U.S. Has considered limiting vaccine access, a departure from previous recommendations.

What the Rise of MEHA Signals

The transatlantic spread of this health-focused movement signals a broader trend of increasing skepticism towards established institutions and a growing demand for greater transparency and individual control over health decisions. While MEHA’s influence remains limited, its emergence within the European Parliament suggests a receptive audience for its message among certain lawmakers. It’s important to note that the movement’s claims regarding vaccine safety and the efficacy of alternative therapies are often contested by mainstream scientific consensus.

The focus on “sovereignty” within MEHA’s messaging also taps into broader political currents in Europe, reflecting concerns about national autonomy and resistance to perceived overreach by international bodies. This framing resonates with populist and nationalist sentiments, potentially broadening the movement’s appeal beyond purely health-related concerns.

Navigating Information and Making Informed Decisions

As MEHA and similar movements gain visibility, it’s crucial for individuals to critically evaluate health information and rely on credible sources. The World Health Organization (WHO) provides comprehensive information on vaccines and other public health issues. The WHO website offers evidence-based guidance and resources for making informed health decisions. Similarly, national health agencies, such as the Centers for Disease Control and Prevention (CDC) in the U.S. And the National Health Service (NHS) in the UK, provide reliable information tailored to their respective populations. The CDC website is a valuable resource for understanding health risks and preventative measures.

It’s also important to remember that correlation does not equal causation. Just because two events occur together does not mean that one causes the other. Scientific studies are designed to investigate potential causal relationships, but even well-designed studies have limitations. Understanding these limitations is crucial for interpreting research findings accurately.

Looking ahead, the impact of MEHA on European health policy remains to be seen. The organization’s ability to mobilize public support and influence lawmakers will be key to its success. Continued monitoring of the movement’s activities and a commitment to evidence-based decision-making will be essential for navigating the evolving landscape of public health in Europe.